ADAR1 has been best characterized in chronic myeloid leukemia (CML), where it has been shown to promote the malignant reprogramming of myeloid progenitors to LICs, LIC self-renewal, and the propagation of malignant progenitors [67–69]. The gene discussed is ADAR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.